PM R, 2014 · DOI: 10.1016/j.pmrj.2013.10.006 · Published: April 1, 2014
After a spinal cord injury (SCI), the body's immune system responds, and cells called macrophages infiltrate the injury site. These macrophages can be pro-inflammatory (M1) or anti-inflammatory (M2). This study looks at monocytes (MOs), which are precursors to macrophages, in the blood of SCI patients. The goal was to see if the type of MOs present in the blood corresponds to the levels of inflammatory substances called cytokines. The study found that SCI patients had different types of MOs in their blood (either M1-dominant or M2-dominant), and these differences were linked to different levels of pro-inflammatory and anti-inflammatory cytokines.
Identifying M1/M2 dominant phenotypes may facilitate future personalized medicine approaches by targeting a subset of SCI patients who are more likely to respond to immune-modulating therapy.
Circulating monocyte phenotype, correlated with inflammatory mediators, may be a feasible biomarker for evaluating SCI outcomes and treatments.
Modulating the immune response by targeting the M1/M2 balance may offer a new avenue for limiting secondary damage and promoting repair in traumatic SCI.